Johnathan Watkins

The Royal Free Hospital — United Kingdom

Health Professions · Health Sciences

22h-index3.9kcitations79works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Global Health Care Issues(11), Employment and Welfare Studies(10), Cancer Genomics and Diagnostics(8), Epigenetics and DNA Methylation(7), BRCA gene mutations in cancer(7)

Publications79 total

Urgent endoscopic submucosal dissection (ESD) of an obstructing, bleeding giant duodenal Brunneroma
Endoscopy·2025
Deep Learning Models for Predicting Malignancy Risk in CT-Detected Pulmonary Nodules: A Systematic Review and Meta-analysis
Lung·2024· 19 citedOpen Access
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK study
BMJ Open·2024· 4 citedOpen Access
Deep learning-based computer-aided diagnostic models <i>versus</i> other methods for predicting malignancy risk in CT-detected pulmonary nodules
2023Open Access
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models
The Lancet Respiratory Medicine·2023· 63 citedOpen Access
Supplementary Methods, Figure Legends, Table Legends from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary Tables S1 - S4 from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary Tables S1 - S4 from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Data from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary Methods, Figure Legends, Table Legends from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figures S1 - S16 from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary File from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Data from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary Figures S1 - S16 from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Supplementary File from Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
2023Open Access
Data from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2023Open Access
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2023Open Access
Data from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2023Open Access
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2023Open Access
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Anita Grigoriadis(15), Andrew Tutt(14), Wahyu Wulaningsih(13), Patrycja Gazińska(12), Mahiben Maruthappu(9), Manar Shafat(7), Maggie C.U. Cheang(7), Sumi Mathew(7), Pierfrancesco Marra(7), Thomas Zeltner(7), Cheryl Gillett(6), Rifat Atun(6), Callum Williams(5), Shalaka Joshi(5), Sarah E. Pinder(5), Hasan Mirza(5), Emanuele de Rinaldis(5), Amina Abdul‐Aziz(4), Kristian M. Bowles(4), Stuart A. Rushworth(4)